instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Presyncope'. | Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction.
Cardiovascular adverse events (CVAEs) are linked to Carfilzomib (CFZ) therapy in multiple myeloma (MM); however, no validated protocols on cardiovascular risk assessment are availab... | CARFILZOMIB | DrugsGivenReaction | CC BY | 33915804 | 19,122,247 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Syncope'. | Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction.
Cardiovascular adverse events (CVAEs) are linked to Carfilzomib (CFZ) therapy in multiple myeloma (MM); however, no validated protocols on cardiovascular risk assessment are availab... | CARFILZOMIB | DrugsGivenReaction | CC BY | 33915804 | 19,122,247 | 2021-04-01 |
What was the outcome of reaction 'Cardiac death'? | Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction.
Cardiovascular adverse events (CVAEs) are linked to Carfilzomib (CFZ) therapy in multiple myeloma (MM); however, no validated protocols on cardiovascular risk assessment are availab... | Fatal | ReactionOutcome | CC BY | 33915804 | 19,122,247 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | SCN8A Encephalopathy: Case Report and Literature Review.
Epileptic encephalopathy is a condition resulting from extreme forms of intractable childhood epilepsy. The disease can cause severe delays in cognitive, sensory, and motor function development, in addition to being fatal in some cases. Missense mutations of SCN8... | LEVETIRACETAM, PHENOBARBITAL, PHENYTOIN SODIUM, VALPROIC ACID | DrugsGivenReaction | CC BY | 33915942 | 20,031,366 | 2021-04-01 |
What is the weight of the patient? | SCN8A Encephalopathy: Case Report and Literature Review.
Epileptic encephalopathy is a condition resulting from extreme forms of intractable childhood epilepsy. The disease can cause severe delays in cognitive, sensory, and motor function development, in addition to being fatal in some cases. Missense mutations of SCN8... | 6.3 kg. | Weight | CC BY | 33915942 | 20,031,366 | 2021-04-01 |
What was the dosage of drug 'LEVETIRACETAM'? | SCN8A Encephalopathy: Case Report and Literature Review.
Epileptic encephalopathy is a condition resulting from extreme forms of intractable childhood epilepsy. The disease can cause severe delays in cognitive, sensory, and motor function development, in addition to being fatal in some cases. Missense mutations of SCN8... | 30 MILLIGRAM/KILOGRAM, QD | DrugDosageText | CC BY | 33915942 | 20,031,366 | 2021-04-01 |
What was the dosage of drug 'PHENOBARBITAL'? | SCN8A Encephalopathy: Case Report and Literature Review.
Epileptic encephalopathy is a condition resulting from extreme forms of intractable childhood epilepsy. The disease can cause severe delays in cognitive, sensory, and motor function development, in addition to being fatal in some cases. Missense mutations of SCN8... | 5 MILLIGRAM/KILOGRAM, QD | DrugDosageText | CC BY | 33915942 | 20,031,366 | 2021-04-01 |
What was the dosage of drug 'VALPROIC ACID'? | SCN8A Encephalopathy: Case Report and Literature Review.
Epileptic encephalopathy is a condition resulting from extreme forms of intractable childhood epilepsy. The disease can cause severe delays in cognitive, sensory, and motor function development, in addition to being fatal in some cases. Missense mutations of SCN8... | 15 MILLIGRAM/KILOGRAM, QD | DrugDosageText | CC BY | 33915942 | 20,031,366 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Herpes Zoster in an Immunocompetent Child without a History of Varicella.
Herpes zoster is a relatively rare infectious disease in the pediatric population, as compared with adults, which is due to the reactivation of latent Varicella-Zoster virus. We report a 7-year-old child without any history of varicella, who firs... | ACYCLOVIR, GABAPENTIN, IBUPROFEN | DrugsGivenReaction | CC BY | 33916031 | 20,583,586 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Herpes Zoster in an Immunocompetent Child without a History of Varicella.
Herpes zoster is a relatively rare infectious disease in the pediatric population, as compared with adults, which is due to the reactivation of latent Varicella-Zoster virus. We report a 7-year-old child without any history of varicella, who firs... | ACYCLOVIR, GABAPENTIN, IBUPROFEN | DrugsGivenReaction | CC BY | 33916031 | 20,583,586 | 2021-04-01 |
What was the administration route of drug 'ACYCLOVIR'? | Herpes Zoster in an Immunocompetent Child without a History of Varicella.
Herpes zoster is a relatively rare infectious disease in the pediatric population, as compared with adults, which is due to the reactivation of latent Varicella-Zoster virus. We report a 7-year-old child without any history of varicella, who firs... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33916031 | 20,583,586 | 2021-04-01 |
What was the administration route of drug 'GABAPENTIN'? | Herpes Zoster in an Immunocompetent Child without a History of Varicella.
Herpes zoster is a relatively rare infectious disease in the pediatric population, as compared with adults, which is due to the reactivation of latent Varicella-Zoster virus. We report a 7-year-old child without any history of varicella, who firs... | Oral | DrugAdministrationRoute | CC BY | 33916031 | 20,583,586 | 2021-04-01 |
What was the dosage of drug 'ACYCLOVIR'? | Herpes Zoster in an Immunocompetent Child without a History of Varicella.
Herpes zoster is a relatively rare infectious disease in the pediatric population, as compared with adults, which is due to the reactivation of latent Varicella-Zoster virus. We report a 7-year-old child without any history of varicella, who firs... | 10 MILLIGRAM/KILOGRAM (RECEIVED ACICLOVIR 10 MG/KG/DOSE EVERY 8 H) | DrugDosageText | CC BY | 33916031 | 20,583,586 | 2021-04-01 |
What was the dosage of drug 'GABAPENTIN'? | Herpes Zoster in an Immunocompetent Child without a History of Varicella.
Herpes zoster is a relatively rare infectious disease in the pediatric population, as compared with adults, which is due to the reactivation of latent Varicella-Zoster virus. We report a 7-year-old child without any history of varicella, who firs... | 10 MILLIGRAM/KILOGRAM, TID ((RECEIVED GABAPENTIN 10 MG/KG/DAY EVERY 8HOURS)) | DrugDosageText | CC BY | 33916031 | 20,583,586 | 2021-04-01 |
What was the dosage of drug 'IBUPROFEN'? | Herpes Zoster in an Immunocompetent Child without a History of Varicella.
Herpes zoster is a relatively rare infectious disease in the pediatric population, as compared with adults, which is due to the reactivation of latent Varicella-Zoster virus. We report a 7-year-old child without any history of varicella, who firs... | 15 MILLIGRAM/KILOGRAM, QID (RECEIVED EVERY 6 HOURS) | DrugDosageText | CC BY | 33916031 | 20,583,586 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anion gap increased'. | Euglycemic Diabetic Ketoacidosis after a Single Dose of Empagliflozin in a Patient with Pancreatitis.
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are the most recently approved drug class for the treatment of type 2 diabetes mellitus (T2D). Although they are largely well-tolerated, their intake has been associat... | EMPAGLIFLOZIN | DrugsGivenReaction | CC BY | 33917274 | 18,422,656 | 2021-04-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Euglycaemic diabetic ketoacidosis'. | Euglycemic Diabetic Ketoacidosis after a Single Dose of Empagliflozin in a Patient with Pancreatitis.
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are the most recently approved drug class for the treatment of type 2 diabetes mellitus (T2D). Although they are largely well-tolerated, their intake has been associat... | EMPAGLIFLOZIN | DrugsGivenReaction | CC BY | 33917274 | 18,422,656 | 2021-04-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metabolic acidosis'. | Euglycemic Diabetic Ketoacidosis after a Single Dose of Empagliflozin in a Patient with Pancreatitis.
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are the most recently approved drug class for the treatment of type 2 diabetes mellitus (T2D). Although they are largely well-tolerated, their intake has been associat... | EMPAGLIFLOZIN | DrugsGivenReaction | CC BY | 33917274 | 18,422,656 | 2021-04-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pancreatitis acute'. | Euglycemic Diabetic Ketoacidosis after a Single Dose of Empagliflozin in a Patient with Pancreatitis.
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are the most recently approved drug class for the treatment of type 2 diabetes mellitus (T2D). Although they are largely well-tolerated, their intake has been associat... | EMPAGLIFLOZIN | DrugsGivenReaction | CC BY | 33917274 | 18,422,656 | 2021-04-06 |
What was the outcome of reaction 'Anion gap increased'? | Euglycemic Diabetic Ketoacidosis after a Single Dose of Empagliflozin in a Patient with Pancreatitis.
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are the most recently approved drug class for the treatment of type 2 diabetes mellitus (T2D). Although they are largely well-tolerated, their intake has been associat... | Recovering | ReactionOutcome | CC BY | 33917274 | 18,422,656 | 2021-04-06 |
What was the outcome of reaction 'Euglycaemic diabetic ketoacidosis'? | Euglycemic Diabetic Ketoacidosis after a Single Dose of Empagliflozin in a Patient with Pancreatitis.
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are the most recently approved drug class for the treatment of type 2 diabetes mellitus (T2D). Although they are largely well-tolerated, their intake has been associat... | Recovering | ReactionOutcome | CC BY | 33917274 | 18,422,656 | 2021-04-06 |
What was the outcome of reaction 'Metabolic acidosis'? | Euglycemic Diabetic Ketoacidosis after a Single Dose of Empagliflozin in a Patient with Pancreatitis.
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are the most recently approved drug class for the treatment of type 2 diabetes mellitus (T2D). Although they are largely well-tolerated, their intake has been associat... | Recovering | ReactionOutcome | CC BY | 33917274 | 18,422,656 | 2021-04-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytokine release syndrome'. | Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma.
Chimeric antigen receptor T (CAR-T) cell therapy has proven to be very effective in patients with relapsed/refrac... | AXICABTAGENE CILOLEUCEL, CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE | DrugsGivenReaction | CC BY | 33918340 | 19,357,405 | 2021-04-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus infection reactivation'. | Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma.
Chimeric antigen receptor T (CAR-T) cell therapy has proven to be very effective in patients with relapsed/refrac... | AXICABTAGENE CILOLEUCEL, CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, FOSCARNET | DrugsGivenReaction | CC BY | 33918340 | 19,357,403 | 2021-04-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus infection'. | Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma.
Chimeric antigen receptor T (CAR-T) cell therapy has proven to be very effective in patients with relapsed/refrac... | AXICABTAGENE CILOLEUCEL, CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, FOSCARNET | DrugsGivenReaction | CC BY | 33918340 | 19,357,402 | 2021-04-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple organ dysfunction syndrome'. | Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma.
Chimeric antigen receptor T (CAR-T) cell therapy has proven to be very effective in patients with relapsed/refrac... | AXICABTAGENE CILOLEUCEL, CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, FOSCARNET | DrugsGivenReaction | CC BY | 33918340 | 19,357,403 | 2021-04-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neurotoxicity'. | Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma.
Chimeric antigen receptor T (CAR-T) cell therapy has proven to be very effective in patients with relapsed/refrac... | AXICABTAGENE CILOLEUCEL, CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, FOSCARNET | DrugsGivenReaction | CC BY | 33918340 | 19,357,403 | 2021-04-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia cytomegaloviral'. | Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma.
Chimeric antigen receptor T (CAR-T) cell therapy has proven to be very effective in patients with relapsed/refrac... | AXICABTAGENE CILOLEUCEL, CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, FOSCARNET | DrugsGivenReaction | CC BY | 33918340 | 19,357,403 | 2021-04-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia respiratory syncytial viral'. | Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma.
Chimeric antigen receptor T (CAR-T) cell therapy has proven to be very effective in patients with relapsed/refrac... | AXICABTAGENE CILOLEUCEL, CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE | DrugsGivenReaction | CC BY | 33918340 | 19,357,405 | 2021-04-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma.
Chimeric antigen receptor T (CAR-T) cell therapy has proven to be very effective in patients with relapsed/refrac... | AXICABTAGENE CILOLEUCEL, CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, FOSCARNET | DrugsGivenReaction | CC BY | 33918340 | 19,357,403 | 2021-04-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Systemic inflammatory response syndrome'. | Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma.
Chimeric antigen receptor T (CAR-T) cell therapy has proven to be very effective in patients with relapsed/refrac... | AXICABTAGENE CILOLEUCEL, CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, FOSCARNET | DrugsGivenReaction | CC BY | 33918340 | 19,357,403 | 2021-04-02 |
What was the outcome of reaction 'Acute kidney injury'? | Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma.
Chimeric antigen receptor T (CAR-T) cell therapy has proven to be very effective in patients with relapsed/refrac... | Not recovered | ReactionOutcome | CC BY | 33918340 | 19,319,316 | 2021-04-02 |
What was the outcome of reaction 'Cytokine release syndrome'? | Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma.
Chimeric antigen receptor T (CAR-T) cell therapy has proven to be very effective in patients with relapsed/refrac... | Recovered | ReactionOutcome | CC BY | 33918340 | 19,357,405 | 2021-04-02 |
What was the outcome of reaction 'Cytomegalovirus infection reactivation'? | Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma.
Chimeric antigen receptor T (CAR-T) cell therapy has proven to be very effective in patients with relapsed/refrac... | Fatal | ReactionOutcome | CC BY | 33918340 | 19,357,403 | 2021-04-02 |
What was the outcome of reaction 'Multiple organ dysfunction syndrome'? | Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma.
Chimeric antigen receptor T (CAR-T) cell therapy has proven to be very effective in patients with relapsed/refrac... | Fatal | ReactionOutcome | CC BY | 33918340 | 19,357,403 | 2021-04-02 |
What was the outcome of reaction 'Pneumonia cytomegaloviral'? | Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma.
Chimeric antigen receptor T (CAR-T) cell therapy has proven to be very effective in patients with relapsed/refrac... | Fatal | ReactionOutcome | CC BY | 33918340 | 19,357,403 | 2021-04-02 |
What was the outcome of reaction 'Pneumonia respiratory syncytial viral'? | Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma.
Chimeric antigen receptor T (CAR-T) cell therapy has proven to be very effective in patients with relapsed/refrac... | Recovered | ReactionOutcome | CC BY | 33918340 | 19,357,405 | 2021-04-02 |
What was the outcome of reaction 'Pneumonia'? | Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma.
Chimeric antigen receptor T (CAR-T) cell therapy has proven to be very effective in patients with relapsed/refrac... | Fatal | ReactionOutcome | CC BY | 33918340 | 19,357,403 | 2021-04-02 |
What was the outcome of reaction 'Systemic inflammatory response syndrome'? | Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma.
Chimeric antigen receptor T (CAR-T) cell therapy has proven to be very effective in patients with relapsed/refrac... | Fatal | ReactionOutcome | CC BY | 33918340 | 19,357,403 | 2021-04-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neurotoxicity'. | Molecular Characterization of Medulloblastoma in a Patient with Neurofibromatosis Type 1: Case Report and Literature Review.
Brain tumors are the most common solid neoplasms of childhood. They are frequently reported in children with Neurofibromatosis type 1 (NF1). The most frequent central nervous system malignancies ... | CISPLATIN, CYCLOPHOSPHAMIDE, VINCRISTINE SULFATE | DrugsGivenReaction | CC BY | 33918520 | 20,183,763 | 2021-04-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Atypical Granulomatosis with Polyangiitis Presenting with Meibomitis, Scleritis, Uveitis and Papillary Bladder Tumor: A Case Report and Literature Review.
Granulomatosis with polyangiitis (GPA) presents with a variety of systemic findings, sometimes with ocular findings initially, but is often difficult to diagnose at ... | BETAMETHASONE, PREDNISOLONE, TROPICAMIDE | DrugsGivenReaction | CC BY | 33918928 | 19,737,719 | 2021-04-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gait disturbance'. | Atypical Granulomatosis with Polyangiitis Presenting with Meibomitis, Scleritis, Uveitis and Papillary Bladder Tumor: A Case Report and Literature Review.
Granulomatosis with polyangiitis (GPA) presents with a variety of systemic findings, sometimes with ocular findings initially, but is often difficult to diagnose at ... | BETAMETHASONE, PREDNISOLONE, TROPICAMIDE | DrugsGivenReaction | CC BY | 33918928 | 19,737,719 | 2021-04-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Muscular weakness'. | Atypical Granulomatosis with Polyangiitis Presenting with Meibomitis, Scleritis, Uveitis and Papillary Bladder Tumor: A Case Report and Literature Review.
Granulomatosis with polyangiitis (GPA) presents with a variety of systemic findings, sometimes with ocular findings initially, but is often difficult to diagnose at ... | BETAMETHASONE, PREDNISOLONE, TROPICAMIDE | DrugsGivenReaction | CC BY | 33918928 | 19,737,719 | 2021-04-09 |
What was the administration route of drug 'BETAMETHASONE'? | Atypical Granulomatosis with Polyangiitis Presenting with Meibomitis, Scleritis, Uveitis and Papillary Bladder Tumor: A Case Report and Literature Review.
Granulomatosis with polyangiitis (GPA) presents with a variety of systemic findings, sometimes with ocular findings initially, but is often difficult to diagnose at ... | Topical | DrugAdministrationRoute | CC BY | 33918928 | 19,737,719 | 2021-04-09 |
What was the administration route of drug 'PREDNISOLONE'? | Atypical Granulomatosis with Polyangiitis Presenting with Meibomitis, Scleritis, Uveitis and Papillary Bladder Tumor: A Case Report and Literature Review.
Granulomatosis with polyangiitis (GPA) presents with a variety of systemic findings, sometimes with ocular findings initially, but is often difficult to diagnose at ... | Oral | DrugAdministrationRoute | CC BY | 33918928 | 19,737,719 | 2021-04-09 |
What was the administration route of drug 'TROPICAMIDE'? | Atypical Granulomatosis with Polyangiitis Presenting with Meibomitis, Scleritis, Uveitis and Papillary Bladder Tumor: A Case Report and Literature Review.
Granulomatosis with polyangiitis (GPA) presents with a variety of systemic findings, sometimes with ocular findings initially, but is often difficult to diagnose at ... | Topical | DrugAdministrationRoute | CC BY | 33918928 | 19,737,719 | 2021-04-09 |
What was the dosage of drug 'TROPICAMIDE'? | Atypical Granulomatosis with Polyangiitis Presenting with Meibomitis, Scleritis, Uveitis and Papillary Bladder Tumor: A Case Report and Literature Review.
Granulomatosis with polyangiitis (GPA) presents with a variety of systemic findings, sometimes with ocular findings initially, but is often difficult to diagnose at ... | THREE TIMES A DAY | DrugDosageText | CC BY | 33918928 | 19,720,253 | 2021-04-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fall'. | Implant-Prosthetic Restoration of a Patient with Osteogenesis Imperfecta: A Case Report.
Osteogenesis imperfecta describes a group of genetic disorders that result from a defect in collagen type I and range in severity from a subtle increase in fracture frequency to death in the perinatal period. Osteogenesis imperfect... | CLINDAMYCIN, DENOSUMAB, PENICILLIN | DrugsGivenReaction | CC BY | 33920808 | 19,934,793 | 2021-04-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Humerus fracture'. | Implant-Prosthetic Restoration of a Patient with Osteogenesis Imperfecta: A Case Report.
Osteogenesis imperfecta describes a group of genetic disorders that result from a defect in collagen type I and range in severity from a subtle increase in fracture frequency to death in the perinatal period. Osteogenesis imperfect... | CLINDAMYCIN, DENOSUMAB, PENICILLIN | DrugsGivenReaction | CC BY | 33920808 | 19,934,793 | 2021-04-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Implant-Prosthetic Restoration of a Patient with Osteogenesis Imperfecta: A Case Report.
Osteogenesis imperfecta describes a group of genetic disorders that result from a defect in collagen type I and range in severity from a subtle increase in fracture frequency to death in the perinatal period. Osteogenesis imperfect... | CLINDAMYCIN, DENOSUMAB, PENICILLIN | DrugsGivenReaction | CC BY | 33920808 | 19,934,793 | 2021-04-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tooth extraction'. | Implant-Prosthetic Restoration of a Patient with Osteogenesis Imperfecta: A Case Report.
Osteogenesis imperfecta describes a group of genetic disorders that result from a defect in collagen type I and range in severity from a subtle increase in fracture frequency to death in the perinatal period. Osteogenesis imperfect... | CLINDAMYCIN, DENOSUMAB, PENICILLIN | DrugsGivenReaction | CC BY | 33920808 | 19,934,793 | 2021-04-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Back pain'. | Unknown Renal Impairment: A Rare Case of Inhaled Tobramycin Induced Acute Kidney Injury in a Cystic Fibrosis Patient.
Acute kidney injury is a reversible medical condition commonly caused by nephrotoxic agents. The infrequency that a nebulized medication elicits a renal insult presents a rare diagnostic challenge. With... | ALBUTEROL, AZITHROMYCIN ANHYDROUS, AZTREONAM, DORNASE ALFA, ELEXACAFTOR\IVACAFTOR\TEZACAFTOR, SODIUM CHLORIDE, TOBRAMYCIN | DrugsGivenReaction | CC BY | 33921466 | 20,556,118 | 2021-04-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chronic kidney disease'. | Unknown Renal Impairment: A Rare Case of Inhaled Tobramycin Induced Acute Kidney Injury in a Cystic Fibrosis Patient.
Acute kidney injury is a reversible medical condition commonly caused by nephrotoxic agents. The infrequency that a nebulized medication elicits a renal insult presents a rare diagnostic challenge. With... | ALBUTEROL, AZITHROMYCIN ANHYDROUS, AZTREONAM, DORNASE ALFA, ELEXACAFTOR\IVACAFTOR\TEZACAFTOR, SODIUM CHLORIDE, TOBRAMYCIN | DrugsGivenReaction | CC BY | 33921466 | 20,556,118 | 2021-04-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Unknown Renal Impairment: A Rare Case of Inhaled Tobramycin Induced Acute Kidney Injury in a Cystic Fibrosis Patient.
Acute kidney injury is a reversible medical condition commonly caused by nephrotoxic agents. The infrequency that a nebulized medication elicits a renal insult presents a rare diagnostic challenge. With... | ALBUTEROL SULFATE, AZITHROMYCIN ANHYDROUS, AZTREONAM, TOBRAMYCIN | DrugsGivenReaction | CC BY | 33921466 | 19,459,660 | 2021-04-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug level increased'. | Unknown Renal Impairment: A Rare Case of Inhaled Tobramycin Induced Acute Kidney Injury in a Cystic Fibrosis Patient.
Acute kidney injury is a reversible medical condition commonly caused by nephrotoxic agents. The infrequency that a nebulized medication elicits a renal insult presents a rare diagnostic challenge. With... | ALBUTEROL, AZITHROMYCIN ANHYDROUS, AZTREONAM, DORNASE ALFA, SODIUM CHLORIDE, TOBRAMYCIN | DrugsGivenReaction | CC BY | 33921466 | 19,460,180 | 2021-04-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Glomerulonephritis'. | Unknown Renal Impairment: A Rare Case of Inhaled Tobramycin Induced Acute Kidney Injury in a Cystic Fibrosis Patient.
Acute kidney injury is a reversible medical condition commonly caused by nephrotoxic agents. The infrequency that a nebulized medication elicits a renal insult presents a rare diagnostic challenge. With... | ALBUTEROL, AZITHROMYCIN ANHYDROUS, AZTREONAM, DORNASE ALFA, ELEXACAFTOR\IVACAFTOR\TEZACAFTOR, SODIUM CHLORIDE, TOBRAMYCIN | DrugsGivenReaction | CC BY | 33921466 | 20,556,118 | 2021-04-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nephrolithiasis'. | Unknown Renal Impairment: A Rare Case of Inhaled Tobramycin Induced Acute Kidney Injury in a Cystic Fibrosis Patient.
Acute kidney injury is a reversible medical condition commonly caused by nephrotoxic agents. The infrequency that a nebulized medication elicits a renal insult presents a rare diagnostic challenge. With... | ALBUTEROL, AZITHROMYCIN ANHYDROUS, AZTREONAM, DORNASE ALFA, ELEXACAFTOR\IVACAFTOR\TEZACAFTOR, SODIUM CHLORIDE, TOBRAMYCIN | DrugsGivenReaction | CC BY | 33921466 | 20,556,118 | 2021-04-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nephropathy toxic'. | Unknown Renal Impairment: A Rare Case of Inhaled Tobramycin Induced Acute Kidney Injury in a Cystic Fibrosis Patient.
Acute kidney injury is a reversible medical condition commonly caused by nephrotoxic agents. The infrequency that a nebulized medication elicits a renal insult presents a rare diagnostic challenge. With... | ALBUTEROL, AZITHROMYCIN ANHYDROUS, AZTREONAM, DORNASE ALFA, SODIUM CHLORIDE, TOBRAMYCIN | DrugsGivenReaction | CC BY | 33921466 | 19,460,180 | 2021-04-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Prostatomegaly'. | Unknown Renal Impairment: A Rare Case of Inhaled Tobramycin Induced Acute Kidney Injury in a Cystic Fibrosis Patient.
Acute kidney injury is a reversible medical condition commonly caused by nephrotoxic agents. The infrequency that a nebulized medication elicits a renal insult presents a rare diagnostic challenge. With... | ALBUTEROL, AZITHROMYCIN ANHYDROUS, AZTREONAM, DORNASE ALFA, ELEXACAFTOR\IVACAFTOR\TEZACAFTOR, SODIUM CHLORIDE, TOBRAMYCIN | DrugsGivenReaction | CC BY | 33921466 | 20,556,118 | 2021-04-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Unknown Renal Impairment: A Rare Case of Inhaled Tobramycin Induced Acute Kidney Injury in a Cystic Fibrosis Patient.
Acute kidney injury is a reversible medical condition commonly caused by nephrotoxic agents. The infrequency that a nebulized medication elicits a renal insult presents a rare diagnostic challenge. With... | ALBUTEROL, AZITHROMYCIN ANHYDROUS, AZTREONAM, DORNASE ALFA, ELEXACAFTOR\IVACAFTOR\TEZACAFTOR, SODIUM CHLORIDE, TOBRAMYCIN | DrugsGivenReaction | CC BY | 33921466 | 20,556,118 | 2021-04-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rectal haemorrhage'. | Unknown Renal Impairment: A Rare Case of Inhaled Tobramycin Induced Acute Kidney Injury in a Cystic Fibrosis Patient.
Acute kidney injury is a reversible medical condition commonly caused by nephrotoxic agents. The infrequency that a nebulized medication elicits a renal insult presents a rare diagnostic challenge. With... | ALBUTEROL, AZITHROMYCIN ANHYDROUS, AZTREONAM, DORNASE ALFA, ELEXACAFTOR\IVACAFTOR\TEZACAFTOR, SODIUM CHLORIDE, TOBRAMYCIN | DrugsGivenReaction | CC BY | 33921466 | 20,556,118 | 2021-04-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal tubular necrosis'. | Unknown Renal Impairment: A Rare Case of Inhaled Tobramycin Induced Acute Kidney Injury in a Cystic Fibrosis Patient.
Acute kidney injury is a reversible medical condition commonly caused by nephrotoxic agents. The infrequency that a nebulized medication elicits a renal insult presents a rare diagnostic challenge. With... | ALBUTEROL, AZITHROMYCIN ANHYDROUS, AZTREONAM, DORNASE ALFA, ELEXACAFTOR\IVACAFTOR\TEZACAFTOR, SODIUM CHLORIDE, TOBRAMYCIN | DrugsGivenReaction | CC BY | 33921466 | 20,556,118 | 2021-04-12 |
What was the administration route of drug 'AZTREONAM'? | Unknown Renal Impairment: A Rare Case of Inhaled Tobramycin Induced Acute Kidney Injury in a Cystic Fibrosis Patient.
Acute kidney injury is a reversible medical condition commonly caused by nephrotoxic agents. The infrequency that a nebulized medication elicits a renal insult presents a rare diagnostic challenge. With... | Respiratory (inhalation) | DrugAdministrationRoute | CC BY | 33921466 | 19,255,727 | 2021-04-12 |
What was the administration route of drug 'ELEXACAFTOR\IVACAFTOR\TEZACAFTOR'? | Unknown Renal Impairment: A Rare Case of Inhaled Tobramycin Induced Acute Kidney Injury in a Cystic Fibrosis Patient.
Acute kidney injury is a reversible medical condition commonly caused by nephrotoxic agents. The infrequency that a nebulized medication elicits a renal insult presents a rare diagnostic challenge. With... | Oral | DrugAdministrationRoute | CC BY | 33921466 | 20,556,118 | 2021-04-12 |
What was the administration route of drug 'TOBRAMYCIN'? | Unknown Renal Impairment: A Rare Case of Inhaled Tobramycin Induced Acute Kidney Injury in a Cystic Fibrosis Patient.
Acute kidney injury is a reversible medical condition commonly caused by nephrotoxic agents. The infrequency that a nebulized medication elicits a renal insult presents a rare diagnostic challenge. With... | Respiratory (inhalation) | DrugAdministrationRoute | CC BY | 33921466 | 19,255,727 | 2021-04-12 |
What was the dosage of drug 'ALBUTEROL'? | Unknown Renal Impairment: A Rare Case of Inhaled Tobramycin Induced Acute Kidney Injury in a Cystic Fibrosis Patient.
Acute kidney injury is a reversible medical condition commonly caused by nephrotoxic agents. The infrequency that a nebulized medication elicits a renal insult presents a rare diagnostic challenge. With... | NEBULIZED | DrugDosageText | CC BY | 33921466 | 19,460,180 | 2021-04-12 |
What was the outcome of reaction 'Acute kidney injury'? | Unknown Renal Impairment: A Rare Case of Inhaled Tobramycin Induced Acute Kidney Injury in a Cystic Fibrosis Patient.
Acute kidney injury is a reversible medical condition commonly caused by nephrotoxic agents. The infrequency that a nebulized medication elicits a renal insult presents a rare diagnostic challenge. With... | Recovering | ReactionOutcome | CC BY | 33921466 | 19,255,727 | 2021-04-12 |
What was the outcome of reaction 'Chronic kidney disease'? | Unknown Renal Impairment: A Rare Case of Inhaled Tobramycin Induced Acute Kidney Injury in a Cystic Fibrosis Patient.
Acute kidney injury is a reversible medical condition commonly caused by nephrotoxic agents. The infrequency that a nebulized medication elicits a renal insult presents a rare diagnostic challenge. With... | Recovering | ReactionOutcome | CC BY | 33921466 | 20,556,118 | 2021-04-12 |
What was the outcome of reaction 'Drug level increased'? | Unknown Renal Impairment: A Rare Case of Inhaled Tobramycin Induced Acute Kidney Injury in a Cystic Fibrosis Patient.
Acute kidney injury is a reversible medical condition commonly caused by nephrotoxic agents. The infrequency that a nebulized medication elicits a renal insult presents a rare diagnostic challenge. With... | Recovering | ReactionOutcome | CC BY | 33921466 | 19,460,180 | 2021-04-12 |
What was the outcome of reaction 'Nephropathy toxic'? | Unknown Renal Impairment: A Rare Case of Inhaled Tobramycin Induced Acute Kidney Injury in a Cystic Fibrosis Patient.
Acute kidney injury is a reversible medical condition commonly caused by nephrotoxic agents. The infrequency that a nebulized medication elicits a renal insult presents a rare diagnostic challenge. With... | Recovering | ReactionOutcome | CC BY | 33921466 | 19,460,180 | 2021-04-12 |
What was the outcome of reaction 'Toxicity to various agents'? | Unknown Renal Impairment: A Rare Case of Inhaled Tobramycin Induced Acute Kidney Injury in a Cystic Fibrosis Patient.
Acute kidney injury is a reversible medical condition commonly caused by nephrotoxic agents. The infrequency that a nebulized medication elicits a renal insult presents a rare diagnostic challenge. With... | Recovering | ReactionOutcome | CC BY | 33921466 | 19,472,843 | 2021-04-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug intolerance'. | Unilateral Orbital Metastasis as the Unique Symptom in the Onset of Breast Cancer in a Postmenopausal Woman: Case Report and Review of the Literature.
The orbit represents an unusual metastases site for patients diagnosed with cancer, however, breast cancer is the main cause of metastases at this level. These orbital m... | ALPRAZOLAM, ANASTROZOLE, CITALOPRAM HYDROBROMIDE, IBANDRONIC ACID, PACLITAXEL | DrugsGivenReaction | CC BY | 33921735 | 19,827,128 | 2021-04-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | Unilateral Orbital Metastasis as the Unique Symptom in the Onset of Breast Cancer in a Postmenopausal Woman: Case Report and Review of the Literature.
The orbit represents an unusual metastases site for patients diagnosed with cancer, however, breast cancer is the main cause of metastases at this level. These orbital m... | ALPRAZOLAM, ANASTROZOLE, CITALOPRAM HYDROBROMIDE, IBANDRONIC ACID, PACLITAXEL | DrugsGivenReaction | CC BY | 33921735 | 19,827,128 | 2021-04-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neuropathy peripheral'. | Unilateral Orbital Metastasis as the Unique Symptom in the Onset of Breast Cancer in a Postmenopausal Woman: Case Report and Review of the Literature.
The orbit represents an unusual metastases site for patients diagnosed with cancer, however, breast cancer is the main cause of metastases at this level. These orbital m... | ALPRAZOLAM, ANASTROZOLE, CITALOPRAM HYDROBROMIDE, IBANDRONIC ACID, PACLITAXEL | DrugsGivenReaction | CC BY | 33921735 | 19,827,128 | 2021-04-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Unilateral Orbital Metastasis as the Unique Symptom in the Onset of Breast Cancer in a Postmenopausal Woman: Case Report and Review of the Literature.
The orbit represents an unusual metastases site for patients diagnosed with cancer, however, breast cancer is the main cause of metastases at this level. These orbital m... | ALPRAZOLAM, ANASTROZOLE, CITALOPRAM HYDROBROMIDE, IBANDRONIC ACID, PACLITAXEL | DrugsGivenReaction | CC BY | 33921735 | 19,810,379 | 2021-04-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | Unilateral Orbital Metastasis as the Unique Symptom in the Onset of Breast Cancer in a Postmenopausal Woman: Case Report and Review of the Literature.
The orbit represents an unusual metastases site for patients diagnosed with cancer, however, breast cancer is the main cause of metastases at this level. These orbital m... | ALPRAZOLAM, ANASTROZOLE, CITALOPRAM HYDROBROMIDE, IBANDRONIC ACID, PACLITAXEL | DrugsGivenReaction | CC BY | 33921735 | 19,827,128 | 2021-04-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Unilateral Orbital Metastasis as the Unique Symptom in the Onset of Breast Cancer in a Postmenopausal Woman: Case Report and Review of the Literature.
The orbit represents an unusual metastases site for patients diagnosed with cancer, however, breast cancer is the main cause of metastases at this level. These orbital m... | ALPRAZOLAM, ANASTROZOLE, CITALOPRAM HYDROBROMIDE, IBANDRONIC ACID, PACLITAXEL | DrugsGivenReaction | CC BY | 33921735 | 19,827,128 | 2021-04-19 |
What was the outcome of reaction 'Febrile neutropenia'? | Unilateral Orbital Metastasis as the Unique Symptom in the Onset of Breast Cancer in a Postmenopausal Woman: Case Report and Review of the Literature.
The orbit represents an unusual metastases site for patients diagnosed with cancer, however, breast cancer is the main cause of metastases at this level. These orbital m... | Recovered | ReactionOutcome | CC BY | 33921735 | 19,827,128 | 2021-04-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ductus arteriosus stenosis foetal'. | The Antenatal and Postnatal Consequences of Antenatal Exposure to Prolonged Low Dose Indomethacin.
Despite its many clinical applications, indomethacin is seldom used in pregnancy, principally because of concerns regarding the potential for constriction of the arterial duct. The aim of this study was to document advers... | INDOMETHACIN | DrugsGivenReaction | CC BY | 33923146 | 19,830,334 | 2021-04-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal exposure during pregnancy'. | The Antenatal and Postnatal Consequences of Antenatal Exposure to Prolonged Low Dose Indomethacin.
Despite its many clinical applications, indomethacin is seldom used in pregnancy, principally because of concerns regarding the potential for constriction of the arterial duct. The aim of this study was to document advers... | INDOMETHACIN | DrugsGivenReaction | CC BY | 33923146 | 19,830,334 | 2021-04-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumothorax'. | The Antenatal and Postnatal Consequences of Antenatal Exposure to Prolonged Low Dose Indomethacin.
Despite its many clinical applications, indomethacin is seldom used in pregnancy, principally because of concerns regarding the potential for constriction of the arterial duct. The aim of this study was to document advers... | INDOMETHACIN | DrugsGivenReaction | CC BY | 33923146 | 19,803,099 | 2021-04-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sepsis'. | The Antenatal and Postnatal Consequences of Antenatal Exposure to Prolonged Low Dose Indomethacin.
Despite its many clinical applications, indomethacin is seldom used in pregnancy, principally because of concerns regarding the potential for constriction of the arterial duct. The aim of this study was to document advers... | INDOMETHACIN | DrugsGivenReaction | CC BY | 33923146 | 19,803,099 | 2021-04-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tricuspid valve incompetence'. | The Antenatal and Postnatal Consequences of Antenatal Exposure to Prolonged Low Dose Indomethacin.
Despite its many clinical applications, indomethacin is seldom used in pregnancy, principally because of concerns regarding the potential for constriction of the arterial duct. The aim of this study was to document advers... | INDOMETHACIN | DrugsGivenReaction | CC BY | 33923146 | 19,830,430 | 2021-04-24 |
What was the administration route of drug 'INDOMETHACIN'? | The Antenatal and Postnatal Consequences of Antenatal Exposure to Prolonged Low Dose Indomethacin.
Despite its many clinical applications, indomethacin is seldom used in pregnancy, principally because of concerns regarding the potential for constriction of the arterial duct. The aim of this study was to document advers... | Transplacental | DrugAdministrationRoute | CC BY | 33923146 | 19,830,334 | 2021-04-24 |
What was the outcome of reaction 'Pneumothorax'? | The Antenatal and Postnatal Consequences of Antenatal Exposure to Prolonged Low Dose Indomethacin.
Despite its many clinical applications, indomethacin is seldom used in pregnancy, principally because of concerns regarding the potential for constriction of the arterial duct. The aim of this study was to document advers... | Fatal | ReactionOutcome | CC BY | 33923146 | 19,803,099 | 2021-04-24 |
What was the outcome of reaction 'Sepsis'? | The Antenatal and Postnatal Consequences of Antenatal Exposure to Prolonged Low Dose Indomethacin.
Despite its many clinical applications, indomethacin is seldom used in pregnancy, principally because of concerns regarding the potential for constriction of the arterial duct. The aim of this study was to document advers... | Fatal | ReactionOutcome | CC BY | 33923146 | 19,803,099 | 2021-04-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cognitive disorder'. | Clinical Remission Using Personalized Low-Dose Intravenous Infusions of N-acetylcysteine with Minimal Toxicities for Interstitial Cystitis/Bladder Pain Syndrome.
Interstitial Cystitis or Bladder Pain Syndrome (IC/BPS) is a heterogeneous condition characterized by elevated levels of inflammatory cytokines, IL-1β, IL-6, ... | AMITRIPTYLINE, ETODOLAC, GABAPENTIN | DrugsGivenReaction | CC BY | 33923265 | 20,841,502 | 2021-04-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Headache'. | Clinical Remission Using Personalized Low-Dose Intravenous Infusions of N-acetylcysteine with Minimal Toxicities for Interstitial Cystitis/Bladder Pain Syndrome.
Interstitial Cystitis or Bladder Pain Syndrome (IC/BPS) is a heterogeneous condition characterized by elevated levels of inflammatory cytokines, IL-1β, IL-6, ... | AMITRIPTYLINE, ETODOLAC, GABAPENTIN | DrugsGivenReaction | CC BY | 33923265 | 20,841,502 | 2021-04-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Clinical Remission Using Personalized Low-Dose Intravenous Infusions of N-acetylcysteine with Minimal Toxicities for Interstitial Cystitis/Bladder Pain Syndrome.
Interstitial Cystitis or Bladder Pain Syndrome (IC/BPS) is a heterogeneous condition characterized by elevated levels of inflammatory cytokines, IL-1β, IL-6, ... | AMITRIPTYLINE, ETODOLAC, GABAPENTIN | DrugsGivenReaction | CC BY | 33923265 | 20,841,502 | 2021-04-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vision blurred'. | Clinical Remission Using Personalized Low-Dose Intravenous Infusions of N-acetylcysteine with Minimal Toxicities for Interstitial Cystitis/Bladder Pain Syndrome.
Interstitial Cystitis or Bladder Pain Syndrome (IC/BPS) is a heterogeneous condition characterized by elevated levels of inflammatory cytokines, IL-1β, IL-6, ... | AMITRIPTYLINE, ETODOLAC, GABAPENTIN | DrugsGivenReaction | CC BY | 33923265 | 20,841,502 | 2021-04-24 |
What was the dosage of drug 'AMITRIPTYLINE'? | Clinical Remission Using Personalized Low-Dose Intravenous Infusions of N-acetylcysteine with Minimal Toxicities for Interstitial Cystitis/Bladder Pain Syndrome.
Interstitial Cystitis or Bladder Pain Syndrome (IC/BPS) is a heterogeneous condition characterized by elevated levels of inflammatory cytokines, IL-1β, IL-6, ... | UNK, LOW DOSES | DrugDosageText | CC BY | 33923265 | 20,841,502 | 2021-04-24 |
What was the dosage of drug 'ETODOLAC'? | Clinical Remission Using Personalized Low-Dose Intravenous Infusions of N-acetylcysteine with Minimal Toxicities for Interstitial Cystitis/Bladder Pain Syndrome.
Interstitial Cystitis or Bladder Pain Syndrome (IC/BPS) is a heterogeneous condition characterized by elevated levels of inflammatory cytokines, IL-1β, IL-6, ... | UNK, LOW DOSES | DrugDosageText | CC BY | 33923265 | 20,841,502 | 2021-04-24 |
What was the dosage of drug 'GABAPENTIN'? | Clinical Remission Using Personalized Low-Dose Intravenous Infusions of N-acetylcysteine with Minimal Toxicities for Interstitial Cystitis/Bladder Pain Syndrome.
Interstitial Cystitis or Bladder Pain Syndrome (IC/BPS) is a heterogeneous condition characterized by elevated levels of inflammatory cytokines, IL-1β, IL-6, ... | UNK, LOW DOSES | DrugDosageText | CC BY | 33923265 | 20,841,502 | 2021-04-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acinetobacter infection'. | Cerebral Toxoplasmosis, CMV and Bacterial Pneumonia with Decreasing CD4+ T-Cell Count as Results of Antiretroviral Therapy Discontinuation-A Case Report.
Cerebral toxoplasmosis occurs mainly in immunocompromised hosts as a reactivation of latent Toxoplasma gondii infection. In the diagnostic process, magnetic resonance... | ABACAVIR, ACYCLOVIR, CILASTATIN SODIUM\IMIPENEM, COLISTIN, DARUNAVIR, EMTRICITABINE, GANCICLOVIR, LAMIVUDINE, LEUCOVORIN, PYRIMETHAMINE, RITONAVIR, SULFADIAZINE, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY | 33924043 | 19,469,754 | 2021-04-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Altered state of consciousness'. | Cerebral Toxoplasmosis, CMV and Bacterial Pneumonia with Decreasing CD4+ T-Cell Count as Results of Antiretroviral Therapy Discontinuation-A Case Report.
Cerebral toxoplasmosis occurs mainly in immunocompromised hosts as a reactivation of latent Toxoplasma gondii infection. In the diagnostic process, magnetic resonance... | GANCICLOVIR, LAMIVUDINE, RITONAVIR, SAQUINAVIR, TENOFOVIR DISOPROXIL | DrugsGivenReaction | CC BY | 33924043 | 19,941,702 | 2021-04-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'CD4 lymphocytes decreased'. | Cerebral Toxoplasmosis, CMV and Bacterial Pneumonia with Decreasing CD4+ T-Cell Count as Results of Antiretroviral Therapy Discontinuation-A Case Report.
Cerebral toxoplasmosis occurs mainly in immunocompromised hosts as a reactivation of latent Toxoplasma gondii infection. In the diagnostic process, magnetic resonance... | ABACAVIR, DARUNAVIR, EMTRICITABINE, LAMIVUDINE, RITONAVIR, SAQUINAVIR, TENOFOVIR | DrugsGivenReaction | CC BY | 33924043 | 19,495,971 | 2021-04-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Central nervous system lesion'. | Cerebral Toxoplasmosis, CMV and Bacterial Pneumonia with Decreasing CD4+ T-Cell Count as Results of Antiretroviral Therapy Discontinuation-A Case Report.
Cerebral toxoplasmosis occurs mainly in immunocompromised hosts as a reactivation of latent Toxoplasma gondii infection. In the diagnostic process, magnetic resonance... | GANCICLOVIR, LAMIVUDINE, RITONAVIR, SAQUINAVIR, TENOFOVIR DISOPROXIL | DrugsGivenReaction | CC BY | 33924043 | 19,941,702 | 2021-04-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cerebral ischaemia'. | Cerebral Toxoplasmosis, CMV and Bacterial Pneumonia with Decreasing CD4+ T-Cell Count as Results of Antiretroviral Therapy Discontinuation-A Case Report.
Cerebral toxoplasmosis occurs mainly in immunocompromised hosts as a reactivation of latent Toxoplasma gondii infection. In the diagnostic process, magnetic resonance... | ABACAVIR, DARUNAVIR, EMTRICITABINE, LAMIVUDINE, RITONAVIR, SAQUINAVIR, TENOFOVIR | DrugsGivenReaction | CC BY | 33924043 | 19,495,971 | 2021-04-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cerebral mass effect'. | Cerebral Toxoplasmosis, CMV and Bacterial Pneumonia with Decreasing CD4+ T-Cell Count as Results of Antiretroviral Therapy Discontinuation-A Case Report.
Cerebral toxoplasmosis occurs mainly in immunocompromised hosts as a reactivation of latent Toxoplasma gondii infection. In the diagnostic process, magnetic resonance... | GANCICLOVIR, LAMIVUDINE, RITONAVIR, SAQUINAVIR, TENOFOVIR DISOPROXIL | DrugsGivenReaction | CC BY | 33924043 | 19,941,702 | 2021-04-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Cerebral Toxoplasmosis, CMV and Bacterial Pneumonia with Decreasing CD4+ T-Cell Count as Results of Antiretroviral Therapy Discontinuation-A Case Report.
Cerebral toxoplasmosis occurs mainly in immunocompromised hosts as a reactivation of latent Toxoplasma gondii infection. In the diagnostic process, magnetic resonance... | ABACAVIR, ACYCLOVIR, CILASTATIN SODIUM\IMIPENEM, COLISTIN, DARUNAVIR, EMTRICITABINE, GANCICLOVIR, LAMIVUDINE, LEUCOVORIN, PYRIMETHAMINE, RITONAVIR, SULFADIAZINE, TENOFOVIR DISOPROXIL FUMARATE | DrugsGivenReaction | CC BY | 33924043 | 19,469,754 | 2021-04-20 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.